VelaLabs was founded in 2006 in the former Novartis Campus in Vienna. Since 2007, it is a GMP-certified service-oriented company with focus on analytical and quality control of biopharmaceutical products, as well as clinical development of biosimilars, biologics and ATMPs. By the acquisition of LABH in 2019, VelaLabs can now also offer all types of microbiological services. Together with its strong team, the VelaLabs Management aims to successfully realize its vision of the future and expand its base of operations.
Among the new goals are digitalization and expansion of its analytical method portfolio for innovative products, as well as GLP certification and ISO 17025 accreditation.
Our philosophy is to support our customers during the journey through the adventure of health.
With our help you have a competent partner in your side for the whole process of drug development that supports you with analytical development, clinical expertise and regulatory consulting.
VelaLabs stands for individual customer support, highest quality standards and professional expertise and we are an international partner for the pharma and biotechnology industry developing biopharmaceuticals and biosimilars.
Our solutions are not out-of-the-box and our flexible and dynamic team can provide tailored solutions for our customers while also having regulatory expertise.
VelaLabs offers analytical test methods for medicinal drugs in the preclinical and clinical development phase. The analytical portfolio is based on International Conference for Harmonization (ICH) guidelines and covers non-cellular and cellular methods. The portfolio is further completed by advisory support for submission-relevant clinical studies and drug product release.
The most important tool for assuring the quality standards of VelaLabs is the GMP certification, which represents the highest level of quality in the pharmaceutical industry. Furthermore, VelaLabs is working compliant with GCLP guidelines for all bioanalytical services.
VelaLabs collaborates with the St. Anna Children’s Hospital, which provides comprehensive care for the children and young people entrusted to them: The concept of the hospital integrates the treatment of patients according to the latest state of medical knowledge, care as support for self-care in close cooperation with caregivers and the psychosocial care of the patients and their families.
Auditreu provides controlling, accounting, tax consulting and payroll to VelaLabs.
VelaLabs is member of Life Science Austria Vienna Region (LISA VR), which provides support and advice to start-ups and high-technology companies.
Vela is partner of the network and cluster of Human Technology Styria.
Biomedica is a leading distributor of medical devices, in-vitro diagnostics and products for Life Sciences. VelaLabs and Biomedica collaborate regarding the implementation, use, marketing and testing services of the GlycoTechnica LecChip technology.
Evercyte offers immortalized cells that retain their primary-like human cell characteristics. VelaLabs and Evercyte have a cooperation for the usage of immortalized cell lines for biosimilar characterization.
Long-term partners of VelaLabs are the Department of Clinical Pharmacology and the Coordination Center for Clinical Studies (KKS) both from the Medical University of Vienna.
BLS – Analytik GmbH & co. KG is a Tentamus laboratory, focusing on the physical, physical-chemical and chemical testing and analysis of pharmaceuticals, food, feed and cosmetic products. BLS is a fully GMP, FDA, and ISO 17025 inspected and approved laboratory.
BAV Institute is an accredited contract laboratory offering hygiene and quality control services in the fields of food, cosmetics, and pharma. In addition to microbial testing, the company specializes in on-site consulting and training.
Protagen Protein Services (PPS) is a leading CRO in protein analytics and its application to GMP-compliant characterization of protein therapeutics. PPS supports multiple biosimilar developers in achieving and demonstrating biosimilarity. Many years of experience of PPS in business and a comprehensive spectrum of validated analytical methods ensure highest quality for customers in the pharmaceutical, biotechnology and life science industry.
Analytical Services provides fully GMP-compliant analytical services and is a FDA registered laboratory. Analytical Services is a partner for orthogonal methods, which are not established at VelaLabs.
MPL Mikrobiologisches Prüflabor GmbH is the GMP certified partner of VelaLabs for microbiological analytics.
VelaLabs’s customers include some of the biggest names in Pharma and Biotech. Our focused, customer – orientated approach, a highly motivated team and a broad expertise in analytical development and quality control led to a trusting relationship that has met the requirements of our customers for over 10 years.
Carnival – we make jelly doughnuts safe
Carnival is approaching fast, and with the fifth season there is also a lot of feasting. Jelly doughnuts are a traditional staple of carnival. To guarantee that carnival remains fun, bilacon test jelly doughnuts to ensure that the carnival season can be celebrated safely. Jelly doughnuts may contain unhealthy substances, which are usually formed
... Continued
Analyst GLP Certification Extension
ISRAC notified Analyst Research Laboratories that it has successfully passed its latest audit and has been rewarded with an extension of its GLP certification. ISRAC is the designated representative of the State of Israel for the recognition of test facilities working; according to GLP. The state of Israel has a mutual recognition GLP agreement with the
... Continued
Laboratorio Control attends Indoor Air Quality conference
Laboratorio Control’s sales team attended one of the key annual meetings on IAC (Indoor Air Quality). This meeting was organized by the Association of Air Conditioning Equipment Manufacturers (AFEC), the Spanish Technical Association of Air Conditioning and Refrigeration (ATECYR) and the Spanish Federation of Indoor Environmental Quality Companies (FEDECAI). During the conference, topics such as
... Continued
Analysis and detection of Tomato Rugose Virus
Tomato brown rugose fruit virus (TBRFV or ToBRFV), also known as Tomato Rugose Virus, is a disease affecting tomatoes which was first observed in Israel in 2014. The disease has recently spread to Europe, the Middle East and North America. Spain, as an important tomato producer, has been closely following the news about detections of
... Continued
Oregon’s long-standing lab has a new brand, same exceptional services
Portland, OR (USA), February 20, 2020 Pixis Labs/ Columbia Food Laboratories merge names to become Columbia Laboratories. Please welcome Columbia Laboratories as the Pacific Northwest’s latest brand for high quality analytical testing. Formerly known collectively as “Pixis Labs” and “Columbia Food Laboratories,” the new name more accurately reflects their consolidated mission to support public
... Continued
Medical Device Regulation: Transitioning from MDD to MDR
On 26 May, 2020, the Medical Device Directive (MDD) will be replaced by the new Medical Device Regulation (MDR). MDR is designed to be an improved version of MDD, with the major difference being that MDR influences and provides effectiveness to all EU member states. This allows MDR to provide a regulation which is consistent
... Continued
